Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

54 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes
Travel Med Infect Dis.
Located in Teams / Vanhems P - PHE3ID / Actualités
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
Verrier et al., Antiviral Research, 2022 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
A new mechanism for perversion of the viro-induced nuclear pore
Bertrand Boson, Chloé Mialon, Konstanze Schichl, Solène Denolly, François-Loïc Cosset. mBio https://doi.org/10.1128/mbio.02923-21
Located in Teams / Cosset FL - EVIR / News
Last publication form the team
Grass, V. et al., Communication Biology 2022, VIV Team.
Located in Teams / Dreux M - VIV / News
Unique molecular signatures typify skin inflammation induced by chemical allergens and irritants
Lefevre MA , Nosbaum A, Rozieres A, Lenief V, Mosnier A, Cortial A, Prieux M, De Bernard S, Nourikyan J, Jouve PE, Buffat L, Hacard F, Ferrier-Lebouedec MC, Pralong P, Dzviga C, Herman A, Baeck M, Nicolas JF, Vocanson M. . Jaci. 2022. 6749(22)00884-3
Located in Teams / Vocanson M - IEA / Actualités
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
Desmares et al., Antiviral Research, 2022 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
The broad viral inhibitors IFITMs can regulate Golgi trafficking
Li Zhong, Yuxin Song, Federico Marziali, Rustem Uzbekov, Xuan-Nhi Nguyen, Chloé Journo, Philippe Roingeard, Andrea Cimarelli
Located in Teams / Cimarelli A - LP2L / News
Association of IFNAR1 and IFNAR2 with COVID-19 severity
The Lancet Microbe: Yaugel-Novoa M., Bourlet T., Longet S., Botehlo-Nevers E, Paul S. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00095-2/fulltext
Located in Teams / Paul S - GIMAP / Actualités
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
Vaccines: Yaugel-Novoa M., Noailly B., Jospin F., Berger A.E., Waeckel L., Botelho-Nevers E., Longet S., Bourlet T., Paul S. https://www.mdpi.com/2076-393X/11/4/773
Located in Teams / Paul S - GIMAP / Actualités
An inventory of adjuvants used for vaccination in horses: the past, the present and the future.
Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO.
Located in Teams / VIDALAIN PO - VIRIMI / News